Compare SSL & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SSL | GRFS |
|---|---|---|
| Founded | 1950 | 1940 |
| Country | South Africa | Spain |
| Employees | 27411 | 25247 |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 5.5B |
| IPO Year | N/A | N/A |
| Metric | SSL | GRFS |
|---|---|---|
| Price | $13.51 | $7.68 |
| Analyst Decision | Sell | Hold |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $10.15 |
| AVG Volume (30 Days) | ★ 1.5M | 590.7K |
| Earning Date | 04-24-2026 | 07-28-2022 |
| Dividend Yield | N/A | ★ 1.80% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3.79 | $4.49 |
| Revenue Next Year | $4.39 | $6.42 |
| P/E Ratio | ★ $13.51 | $18.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.90 | $7.39 |
| 52 Week High | $14.37 | $11.14 |
| Indicator | SSL | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 56.03 | 39.40 |
| Support Level | $11.82 | $7.39 |
| Resistance Level | $13.68 | $9.78 |
| Average True Range (ATR) | 0.33 | 0.22 |
| MACD | -0.09 | -0.06 |
| Stochastic Oscillator | 57.66 | 16.06 |
Sasol Ltd operates as a vertically integrated chemicals and energy company through its two main businesses: the Southern Africa Energy & Chemicals business and the International Chemical business. It generates maximum revenue from the Southern Africa Energy & Chemicals business, which operates integrated value chains with feedstock sourced from the Mining and Gas operating segments. Geographically, the company generates the majority of its revenue from South Africa.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.